Central Garden & Pet Rallies 18% in a Month, Shorts Retreat
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
CENT.A enters its November 25 earnings window riding an 18% one-month price gain to $40.43, with short sellers cutting positions steadily and the borrow market as loose as it has been all year.
The most striking feature of the current setup is the pace at which short sellers have been unwinding. Short interest has dropped 14% over the past month and is now 13% lower on the week, pulling the total to around 2.5% of free float. That is a low level by almost any measure, and the direction is clearly away from the name. The borrow market echoes the same message: availability is near its loosest in 52 weeks, with more than 40 million shares available in the lending pool against roughly 1.3 million currently borrowed. Cost to borrow has edged down about 8% on the week to just 0.26%, well within the general stock range. There is no meaningful squeeze dynamic here, and no signal of fresh short conviction building.
Options activity adds a different angle. The put/call ratio has been running at zero for the past two weeks, meaning only calls have traded, compared to a 20-day mean closer to 0.4. That reads as a purely call-sided market, though with a 52-week PCR high of 20 in the record and such thin options flow, the signal is difficult to weight heavily. The ORTEX short score has drifted lower, from 37.1 on October 26 down to 34.5 this week, a direction consistent with the short interest retreat and placing it in the lower third of the universe on short-pressure indicators.
The Street's view is broadly constructive on valuation, though not aggressively so. The stock trades at 13.1 times trailing earnings and 8.3 times EV/EBITDA, both multiples expanding meaningfully through October as the share price rallied. Price-to-book has climbed to 1.2, up about 0.18 over the past 30 days, reflecting the re-rating. The earnings yield factor ranks in the 77th percentile, suggesting the stock still screens reasonably on value relative to its universe despite the recent move. The analyst recommendation differential scores around the 51st percentile, broadly neutral.
On the institutional side, BlackRock is the standout number. The latest reported position is approximately 29% of shares outstanding, a figure that is likely partly explained by the dual-class share structure, but BlackRock also recently filed a fresh Schedule 13G for a subsidiary position. The overall holder count registers 244 institutions, and American Century added roughly 550,000 shares in its most recent filing. Insider activity over the past 90 days netted a small sell of around 13,900 shares at an aggregate value of about $540,000, concentrated in the Chairman and a divisional president making open-market sales in August at prices around $38 to $39. Those levels are now below the current price, which adds a modest positive frame to the stock's progress since those transactions.
The last earnings print, in August, saw the stock move 5% higher the following day before fading back to near-flat on a five-day view. With results now 22 days away on November 25, the setup to watch is whether the combination of declining short interest, a loose borrow market and multiple expansion through October is confirmed or tested by the next set of numbers.
Stocks in this article
See the live data behind this article on ORTEX.
Open CENT.A on ORTEX →How this article was generated
- Generated
- 3 Nov 2026, 17:36
- Data as of
- 3 Nov 2026, 17:35
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.